Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABCB1/P-glycoprotein as biological marker for treatment of patients with high grade osteosarcoma
2011-001659-36Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methotrexate, cisplatin, doxorubicin, ifosfamide and mifamurtide in osteosarcoma (OS), sponsored by Italian Sarcoma Group. Primary endpoint: Overall survival. Started Sep 2011; status: completed.
02
Drugs
methotrexatecisplatindoxorubicinifosfamidemifamurtide
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on 2011-001659-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001659-36.